This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The existing oral and intravenous forms of bumetanide are commonly prescribed for people with heartfailure because they ease tissue swelling, a common cause of symptoms for people with heartfailure.
In adults with congenital heartdisease (ACHD patients), atrial arrhythmias (AA) and heartfailure (HF) are common. 1 Factors related to congenital heartdisease, such as underlying anatomy, surgical repair technique and scars, can all be considered as AA substrates.
Statement Highlights: Previous studies have found that 14-81% of patients with heartfailure experience some degree of cognitive impairment affecting language, memory or executive function. Evidence also indicates that people with atrial fibrillation.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Background Atrial arrhythmias (AA) and heartfailure (HF) are major causes of hospitalisation in adult congenital heartdisease (ACHD). Methods In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed.
Heartfailure (HF) is a complex syndrome which leads to significant morbidity and mortality, poor quality of life and extremely high costs to healthcare systems worldwide. In this review, we aim to comprehensively describe the burden of HF from an LMIC perspective, based on the more recent available data.
Three common cardiovascular diseases in adults—heartfailure, atrial fibrillation and coronary heartdisease—are linked to cognitive impairment and increased risk of dementia, according to "Cardiac Contributions to Brain Health," a new scientific statement from the American Heart Association published today in the journal, Stroke.
In mice, this protein was able to restore the heart by activating dormant repair genes without causing side effects, such as heart enlargement. This study marks an important step toward regenerative therapies to prevent heartfailure.
A new small study has revealed the impact of obesity on muscle structure in patients having a form of heartfailure called heartfailure with a preserved ejection fraction (HFpEF).
Researchers have reduced scar formation and improved heart function in mouse models of heartfailure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other conditions.
A new American Heart Association scientific statement suggests addressing cardiovascular health earlier in life may reduce the risk of stroke and help preserve thinking and memory later in life.
A novel study co-authored by a heartfailure cardiologist demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
Heartfailure during pregnancy is a dangerous and often under-detected condition because common symptoms -- shortness of breath, extreme fatigue and trouble breathing while lying down -- are easily mistaken for typical pregnancy discomforts.
Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heartfailure that affects millions worldwide.
A critical review of cell-based and cell product-based therapies for the treatment of heartfailure details 20 years of completed and ongoing clinical trials. While none has yet gained medical approval, pathways to new treatments for heartfailure can take decades, as seen for two other, now accepted therapies.
A mouse study of heartfailure with preserved ejection fraction (HFpEF) found male-female differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
For adults with congenital heartdisease (ACHD), those with heartfailure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
In ambulatory women ages 63-99 years, higher amounts of usual daily light and moderate intensity activities were associated with lower risk of developing heartfailure with preserved ejection fraction independent of demographic and clinical factors associated with heartfailure risk.
Care for survivors after an acute attack of COVID-19 should include paying close attention to cardiovascular health and disease.Systematic Review RegistrationPROSPERO [CRD42022353965].
Pre-eclampsia and heartfailure have common risk factors, including hypertension, obesity and diabetes. It is not known whether heartfailure increases the risk of pre-eclampsia. This study examines whether pregestational heartfailure increases the risk of pre-eclampsia.
An analysis based on a proposed heartfailure risk prediction tool reveals that the incidence of heartfailure may be 2- to 3-fold higher among American Indian adults compared to people in other population groups.
A recent study utilized a machine learning-based approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heartfailure (ADHF).
announced that the peer-reviewed Journal of the American College of Cardiology: HeartFailure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heartfailure using commonly accepted willingness-to-pay thresholds. “Our healthcare system.
Henry Ford Health's Center for Structural HeartDisease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heartfailure patient on February 13, 2024 at Henry Ford Hospital in Detroit. She is only the third patient in the U.S. to receive the device.
According to a recent study, high levels of sedentary behavior and physical inactivity from childhood strain the heart in adolescence. High cardiac workload predicts heartfailure and other heartdiseases.
Researchers have found a potential method to slow heartfailure progression. They fed mice a diet high in soybean protein, which influenced gut bacteria and supported heart health. Analysis showed that this diet increased the production of the short-chain fatty acids in the gut that help to protect the heart.
In a new study, researchers show that elevated levels of proteins related to cellular senescence, or aging, in the blood and the placenta are linked to this form of heartfailure.
Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments for atrial fibrillation and heartfailure.
It found the strongest links with risks of high blood pressure, ischemic heartdisease and heartfailure. The study is the first of its kind to look at cardiovascular health after perinatal depression and included data on around 600,000 women.
Abstract Worldwide, valvular heartdisease (VHD) is a common cause of hospitalization for acute heartfailure. In acute heartfailure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heartfailure. A higher mortality rate was observed among children under three months of age with congenital heartdisease.
New research has shown that over the long-term, standing more compared with sitting does not improve cardiovascular health (coronary heartdisease, stroke and heartfailure), and could increase the risk of circulatory issues related to standing, such as varicose veins and deep vein thrombosis.
The researchers looked at data from 4,286 people -- out of a total of 17,605 from the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial who were randomly assigned either semaglutide or a placebo -- who were followed up over an average of more than three years.
Diabetic heartdisease may eventually lead to heartfailure, a leading cause of mortality in diabetic individuals. The lack of effective treatments for diabetes-induced heartfailure may result from a failure.
These “off the shelf” mesenchymal stem cells (MSC) utilized for the study treatment are immunomodulatory with potential for impact on inflammatory processes in heartfailure and have been shown to release multiple critical angiogenic factors that can enhance microvascular function and capillary networks in ischemic tissues.
Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heartfailure and reduced ejection fraction (HFrEF). BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.34), ischaemic heartdisease (HR 1.20, 95% CI 1.09–1.31),
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content